Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005304189 | SCV005959175 | uncertain significance | Inborn genetic diseases | 2024-12-13 | criteria provided, single submitter | clinical testing | The p.L38F variant (also known as c.112C>T), located in coding exon 2 of the USB1 gene, results from a C to T substitution at nucleotide position 112. The leucine at codon 38 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |